Aripiprazole in Children and Adolescents with Tourette's Disorder: An Open-Label Safety and Tolerability Study
- 1 December 2009
- journal article
- clinical trial
- Published by SAGE Publications in Journal of Child and Adolescent Psychopharmacology
- Vol. 19 (6) , 623-633
Abstract
The aim of this study was to conduct a prospective safety and tolerability study of aripiprazole for the treatment of tics in children and adolescents with Tourette's disorder (TD). Eleven subjects (10 males) with TD (age 9-19 years, mean 13.36, standard deviation [SD] 3.33) who did not respond or were unable to tolerate previous tic medication were treated with aripiprazole in an open-label, flexible-dosing study over 10 weeks. Tic severity was rated using the Yale Global Tic Severity Scale (YGTSS) and the Clinical Global Impressions Scale for tics (CGI-Tics) at baseline and at follow-up. The mean (+/-SD) daily dose for aripiprazole was 4.5 +/- 3.0 mg. Mean (+/-SD) YGTSS Global Severity scores reduced from 61.82 +/- 13.49 at baseline to 33.73 +/- 15.18 at end point; mean YGTSS total tic scores reduced from 28.18 +/- 7.74 at baseline to 16.73 +/- 7.54 at end point. Mean (+/-SD) CGI-Tic severity scores reduced from 4.45 +/- 0.52 (moderate-marked) at baseline to 3.18 +/- 0.60 (mild) at end point. On the CGI-Tic improvement scale, 10 (91%) subjects achieved 1 ("very much improved") or 2 ("much improved") at end point. Most common adverse effects included appetite increase and weight gain in 5 subjects, mild extrapyramidal effects in 7 subjects, and headaches and tiredness/fatigue in 7 subjects; 1 subject experienced akathisia and muscle cramps. Aripiprazole appears to be a safe and tolerable treatment in children and adolescents with TD that appears to reduce tics; it should be further investigated as a treatment option in controlled trials.Keywords
This publication has 31 references indexed in Scilit:
- Pimozide for tics in Tourette's syndromeCochrane Database of Systematic Reviews, 2009
- The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical useJournal of Evaluation in Clinical Practice, 2008
- Aripiprazole in Children and Adolescents with Tourette Disorder with and without Explosive OutburstsJournal of Child and Adolescent Psychopharmacology, 2008
- Aripiprazole in a Case Presenting With Tourette Syndrome and Obsessive-Compulsive DisorderJournal of Clinical Psychopharmacology, 2008
- Aripiprazole: A treatment for severe coprolalia in “refractory” Gilles de la Tourette syndromeMovement Disorders, 2007
- Aripiprazole is effective in the treatment of Tourette's disorderInternational Journal of Neuropsychopharmacology, 2006
- Aripiprazole in Childhood and Adolescence for Tourette SyndromeJournal of Child Neurology, 2006
- Case series on the use of aripiprazole for Tourette syndromeInternational Journal of Neuropsychopharmacology, 2005
- Aripiprazole in a Patient Vulnerable to Side EffectsAmerican Journal of Psychiatry, 2005
- Aripiprazol e síndrome de TouretteBrazilian Journal of Psychiatry, 2004